Skip to main content

Table 4 SUD-16 measure at baseline and 6 months following initial facility visit, ranked ordered by the magnitude of within-facility difference

From: Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration

 

SUD-16 at baselinea (%)

SUD-16 at 6 months post facility visita (%)

Difference in SUD-16 (6-month baseline) (%)

95% CIb

Facility 6

34.9

31.3

− 3.6

(− 9.5 to 2.2%)

Facility 1

4.0

7.4

3.4

(− 4.4 to 12.4%)

Facility 7

18.8

23.1

4.3

(− 0.7 to 9.3%)

Facility 3

10.4

17.3

6.9

(− 0.7 to 14.5%)

Facility 8

28.5

35.6

7.1

(− 0.4 to 14.5%)

Facility 2

15.6

23.3

7.7

(− 2.7 to 18.2%)

Facility 4

4.1

12.5

8.4

(4.4 to 12.4%)‡

Facility 5

19.2

29.1

9.9

(3.6 to 16.2%)‡

  1. aQuarterly SUD-16 measures
  2. bWithout patient level data, independent percent proportions are assumed at each time point
  3. ‡Statistically significant at p < 0.05